Comparative Evaluation of the Long-Term Efficacy and Safety of the Infliximab Biosimilar BCD-055 and Reference Infliximab in Patients With Ankylosing Spondylitis: Results of the International Multicenter Randomized Double-Blind Phase Iii Clinical Study Asart-2
Nauchno-Prakticheskaya Revmatologiya - Russian Federation
doi 10.14412/1995-4484-2018-293-301
Full Text
Open PDFAbstract
Available in full text
Date
July 15, 2018
Authors
Publisher
IMA Press, LLC